about
Current aspects of vitiligo geneticsDysfunction of Autophagy: A Possible Mechanism Involved in the Pathogenesis of Vitiligo by Breaking the Redox Balance of MelanocytesMelanocytes and their diseasesImmune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.Vitiligo: a possible model of degenerative diseases.Stress-induced RNASET2 overexpression mediates melanocyte apoptosis via the TRAF2 pathway in vitro.The effect of pseudocatalase/superoxide dismutase in the treatment of vitiligo: A pilot studyCXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.Th17 cells and activated dendritic cells are increased in vitiligo lesionsThe incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment.Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo.Vitiligo: an evidence-based update. Report of the 13th Evidence Based Update Meeting, 23 May 2013, Loughborough, U.K.Interferon-γ induces senescence in normal human melanocytes.Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis.Differential responses of normal human melanocytes to intra- and extracellular dsRNAEffect of excimer laser treatment on vitiliginous areas with leukotrichia after confirmation by dermoscopy.Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C.Translation, cross-cultural adaptation and validation of the vitiligo-specific health-related quality of life instrument (VitiQoL) into Brazilian Portuguese[Treatment of vitiligo].Pediatric Patients with Vitiligo in Eastern China: Abnormalities in 145 Cases Based on Thyroid Function Tests and Immunological FindingsCellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo.Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference.Recent progress in the genetics of generalized vitiligo.Serum Homocysteine and Total Antioxidant Status in Vitiligo: A Case Control Study in Indian Population."Pseudo" Nomenclature in Dermatology: What's in a Name?Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells.Clinical course of segmental vitiligo: a retrospective study of eighty-seven patients.Vitiligo, reactive oxygen species and T-cells.Tumor necrosis factor-α in vitiligo: direct correlation between tissue levels and clinical parameters.Vitiligo as an inflammatory skin disorder: a therapeutic perspective.Beyond vitiligo guidelines: combined stratified/personalized approaches for the vitiligo patient.Accelerating bleaching in vitiligo: balancing benefits versus risks.Oxidative stress and immune system in vitiligo and thyroid diseases.Alternative Systemic Treatments for Vitiligo: A Review.Vitiligo: An Update on Pathophysiology and Treatment Options.Whole Transcriptome Analysis (RNA Sequencing) of Peripheral Blood Mononuclear Cells of Vitiligo Patients.Aquaporin 3 and E-Cadherin Expression in Perilesional Vitiligo Skin.
P2860
Q27003993-D845BBAA-EA06-4043-9293-405A3047A380Q28067630-192B0578-5EE8-474A-9863-30C2426DFB52Q28658506-E52C336F-07CD-4FAC-AAC3-307D3D497DE2Q30371711-84E450AB-9152-4018-99D0-9CDEB18E96CBQ30433217-5E8A8C7F-AD24-4D63-862C-B8B294B02B7FQ33355586-9418C1BB-E879-464B-88A2-A697282AACFAQ33695164-9FDB5BFC-8452-4CAA-ACCA-6363B4D47B2CQ33827875-16AFBB8E-2C6A-4918-9526-760D52C7AC53Q33864128-FBF862E0-DA13-4534-8EFC-CBFA878A694CQ33889471-C6290050-C580-427E-A24C-CF97336E9DAEQ33968832-96776C6E-BE3B-41B5-A729-4CBB489850ECQ34110126-1C62FE30-C182-4A9A-B5EB-39D068D10254Q34533598-7B2AD5CB-FDA6-48F2-AAD3-0E8334722B7CQ34731431-53BEB903-0EF0-4F67-BBF2-A1DA9C19667EQ35019101-42494E17-5235-4EFD-A865-0E1A1421A375Q35134926-8850AB0A-041A-453F-BE44-4E39B528C96DQ35672638-4B3290C1-7C3D-4A10-B86C-CC5BE0F6D063Q35799552-CB469ECF-485E-4EF0-BBFB-A80E7E7D821EQ35820417-C9974DD6-5E23-47F4-A603-941319094B66Q35833086-40F07987-81D1-4A6E-B602-0D6AF49649B5Q35892146-35476579-9140-453B-8AC9-6840D3D3E9BDQ35933801-D0F5205E-074C-4C30-BBB3-8024EED1D453Q36232253-5682A185-FC9C-4470-8F60-5045F3F9AFE8Q36389114-FFB0DACD-9C22-44EF-9E02-BC5BD6629D0AQ36438695-F3512764-56A1-4B28-9A9E-E97AB817F6B2Q36441780-917CE08A-D544-493A-BB3F-F3B96A2F6D86Q36755821-81C9CA33-479F-4448-B585-0C284677DB0DQ37187055-61666334-E915-4A31-AA8D-862709E08C68Q37240967-D973F283-2457-48C0-A577-F5B8342C070AQ37641930-606D99B2-0A95-4363-8182-6444D02BBC7EQ37801388-601325B9-ACA0-46B9-9E85-163640D3BACCQ37851134-C5DB87A7-9F9A-4EFC-B24E-EE0F1ACFD9BEQ37958249-0ECD27D8-2067-44C9-A3C9-A5FF698E64E2Q38187446-2A3CE6AD-A3DB-4777-87F4-2588667CF33EQ38231335-F1D6A317-38B0-4F19-822C-CE65E8ED953AQ38403600-3076B5FC-E15F-4269-83EA-F6308E994EB0Q38578548-BF176E3D-1BB1-4B6D-9FC8-F836904048CFQ38675361-CA0FB862-9918-4F9E-9F8F-22B29535C81BQ38700035-30A7961C-0EC0-43B9-B3D6-A555A64DE230Q38956815-EDF34062-6089-4061-9A1C-A3926C874B42
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical practice. Vitiligo.
@en
Clinical practice. Vitiligo.
@nl
type
label
Clinical practice. Vitiligo.
@en
Clinical practice. Vitiligo.
@nl
prefLabel
Clinical practice. Vitiligo.
@en
Clinical practice. Vitiligo.
@nl
P356
P1476
Clinical practice. Vitiligo.
@en
P2093
Alain Taïeb
P304
P356
10.1056/NEJMCP0804388
P407
P577
2009-01-01T00:00:00Z